Skip to main content

Table 3 Treatment of incident and prevalent patients following diagnosis

From: Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry

Treatment, n Incident (n = 91) Prevalent (n = 100)
Calcium channel blockers 3 2
Bosentan 27 25
Sildenafil 35 31
Treprostinil 4 5
Epoprostenol - 1
Combination therapy 11 26
  Bosentan + sildenafil 3 14
  Bosentan + iloprost 2 -
  Sildenafil + iloprost 2 2
  Sildenafil + treprostinil 2 4
  Sildenafil + epoprostenol 2 4
  Epoprostenol + sildenafil + bosentan - 2
Investigational drugs 7 5
No specific therapy 4 5